[1]Patent:KR2016/142676,2016,A.Locationinpatent:Paragraph0061;0098;0099;0100;0133;0134;0159
[2]JournalofMedicinalChemistry,2006,vol.49,p.329-333
[3]BioorganicandMedicinalChemistryLetters,2011,vol.21,p.4520-4523
[4]JournalofMedicinalChemistry,2011,vol.54,p.5395-5402
[5]JournaloftheChemicalSociety.PerkintransactionsI,1982,p.1157-1162
[6]JournaloftheAmericanChemicalSociety,1956,vol.78,p.832,837
[7]ChemBioChem,2014,vol.15,p.1325-1333
Title: Discovery of naturally occurring aurones that are potent allosteric inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Journal: Journal of medicinal chemistry 20110801
Title: Synthesis of aurones and their inhibitory effects on nitric oxide and PGE2 productions in LPS-induced RAW 264.7 cells.
Journal: Bioorganic & medicinal chemistry letters 20110801
Title: 1-Azaaurones derived from the naturally occurring aurones as potential antimalarial drugs.
Journal: Bioorganic & medicinal chemistry 20100801
Title: Functionalized aurones as inducers of NAD(P)H:quinone oxidoreductase 1 that activate AhR/XRE and Nrf2/ARE signaling pathways: synthesis, evaluation and SAR.
Journal: European journal of medicinal chemistry 20100701
Title: Integrated metabolite and transcript profiling identify a biosynthetic mechanism for hispidol in Medicago truncatula cell cultures.
Journal: Plant physiology 20091101
Title: Discovery of benzylidenebenzofuran-3(2H)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes.
Journal: Journal of medicinal chemistry 20060112
Title: Evaluation of in vitro activity of aurones and related compounds against Cryptosporidium parvum.
Journal: Planta medica 20011101
Title: Kadayat TM, et al. Discovery and structure-activity relationship studies of 2-benzylidene-2,3-dihydro-1H-inden-1-one and benzofuran-3(2H)-one derivatives as a novel class of potential therapeutics for inflammatory bowel disease. Eur J Med Chem. 2017 Sep 8;137:575-597.
